Carlos Capela

  • Host Genetics
  • Autoimmune Diseases
  • Chronic Ulcers
  • Buruli Ulcer
  • Phage Therapy
  • Clinical Research

Carlos Capela is a medical doctor, specialist in Internal Medicine since 2011 and a graduate assistant since 2021. He currently works at the Hospital de Braga, dedicating himself to systemic autoimmune diseases, immunodeficiencies, chronic diseases (congestive heart failure, ulcerative cutaneous diseases, etc) and infectious diseases. He is also a full invited assistant professor at the School of Medicine – University of Minho and a researcher associated with the Life and Health Sciences Research Institute (ICVS), Clinical Academic Center (2CA-Braga) and P5 – Digital Medicine Centre. Carlos Capela completed his PhD in Medicine in 2017 and has since been actively involved in establishing an international partnership with the “Programme National de Lutte Contre la Lèpre et l’Ulcère de Buruli”, which allowed the active collection of clinical data and biological samples from Buruli ulcer patients at the Centre de Dépistage et de Traitement de l’Ulcère de Buruli from Pobé and Allada in Benin, Africa. His research interests focus on genomic data analysis and identification of relevant genes and coding variants involved in the increased resistance/susceptibility to the development of Buruli ulcer.

Carlos Capela

  • Host Genetics
  • Autoimmune Diseases
  • Chronic Ulcers
  • Buruli Ulcer
  • Phage Therapy
  • Clinical Research

Carlos Capela is a medical doctor, specialist in Internal Medicine since 2011 and a graduate assistant since 2021. He currently works at the Hospital de Braga, dedicating himself to systemic autoimmune diseases, immunodeficiencies, chronic diseases (congestive heart failure, ulcerative cutaneous diseases, etc) and infectious diseases. He is also a full invited assistant professor at the School of Medicine – University of Minho and a researcher associated with the Life and Health Sciences Research Institute (ICVS), Clinical Academic Center (2CA-Braga) and P5 – Digital Medicine Centre. Carlos Capela completed his PhD in Medicine in 2017 and has since been actively involved in establishing an international partnership with the “Programme National de Lutte Contre la Lèpre et l’Ulcère de Buruli”, which allowed the active collection of clinical data and biological samples from Buruli ulcer patients at the Centre de Dépistage et de Traitement de l’Ulcère de Buruli from Pobé and Allada in Benin, Africa. His research interests focus on genomic data analysis and identification of relevant genes and coding variants involved in the increased resistance/susceptibility to the development of Buruli ulcer.

Scientific Highlights

1. Identification of host genetic factors associated with suscpetibility/resistance to Buruli Ulcer.

2. Contribution to elucidate time-related lesions evolution in Buruli-ulcer patients;

3. Contribution to understanding the immune response to SARS-CoV-2 infection;

Add Your Heading Text Here

Projects

As Leader

Projects

As Member